D-Index & Metrics Best Publications
Neuroscience
Switzerland
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Neuroscience D-index 88 Citations 36,282 303 World Ranking 677 National Ranking 14
Medicine D-index 90 Citations 37,286 325 World Ranking 7537 National Ranking 112

Research.com Recognitions

Awards & Achievements

2022 - Research.com Neuroscience in Switzerland Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Parkinson's disease
  • Psychiatry

Paul Krack mainly focuses on Parkinson's disease, Subthalamic nucleus, Deep brain stimulation, Neuroscience and Levodopa. His Parkinson's disease research includes elements of Central nervous system disease, Surgery, Apathy and Physical medicine and rehabilitation. Paul Krack has researched Subthalamic nucleus in several fields, including Anesthesia, Premovement neuronal activity, Stimulation, Stereotaxic technique and Degenerative disease.

In his research on the topic of Anesthesia, Dementia is strongly related with Ablative brain surgery. His Deep brain stimulation research includes themes of Verbal fluency test, Parkinsonism, Dystonia, Physical therapy and Severity of illness. His Levodopa study deals with Dopaminergic intersecting with Dopamine dysregulation syndrome and Punding.

His most cited work include:

  • A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease (1930 citations)
  • Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. (1723 citations)
  • Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease (1547 citations)

What are the main themes of his work throughout his whole career to date?

Paul Krack spends much of his time researching Parkinson's disease, Deep brain stimulation, Neuroscience, Subthalamic nucleus and Levodopa. His work carried out in the field of Parkinson's disease brings together such families of science as Physical medicine and rehabilitation, Dopaminergic, Dopamine, Apathy and Physical therapy. His studies deal with areas such as Dystonia, Movement disorders and Quality of life as well as Deep brain stimulation.

Neuroscience and Subthalamic nucleus stimulation are frequently intertwined in his study. He usually deals with Subthalamic nucleus and limits it to topics linked to Stimulation and Adverse effect. His Levodopa study combines topics in areas such as Surgery, Audiology, Dyskinesia, Parkinsonism and Pallidotomy.

He most often published in these fields:

  • Parkinson's disease (82.73%)
  • Deep brain stimulation (59.61%)
  • Neuroscience (54.04%)

What were the highlights of his more recent work (between 2017-2021)?

  • Parkinson's disease (82.73%)
  • Deep brain stimulation (59.61%)
  • Disease (27.30%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Parkinson's disease, Deep brain stimulation, Disease, Subthalamic nucleus and Physical medicine and rehabilitation. Paul Krack interconnects Apathy, Dopaminergic and Stimulation, Neuroscience in the investigation of issues within Parkinson's disease. His Deep brain stimulation research incorporates elements of Dystonia, Quality of life, Randomized controlled trial and Cohort.

His Quality of life research integrates issues from Anesthesia and Physical therapy. The study incorporates disciplines such as Pathological and Neurology in addition to Disease. His Subthalamic nucleus research is multidisciplinary, incorporating elements of Obsessive compulsive, Basal ganglia, Cohort study and Subthalamic stimulation.

Between 2017 and 2021, his most popular works were:

  • Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. (57 citations)
  • Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. (57 citations)
  • Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond. (35 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Parkinson's disease
  • Disease

His primary areas of study are Parkinson's disease, Disease, Deep brain stimulation, Neuroscience and Subthalamic nucleus. His Parkinson's disease study is related to the wider topic of Internal medicine. His Disease study incorporates themes from Quality of life and Intensive care unit.

As a part of the same scientific study, he usually deals with the Deep brain stimulation, concentrating on Randomized controlled trial and frequently concerns with Gait. His research in Subthalamic nucleus intersects with topics in Valence, Stimulation and Local field potential. His research in Stimulation focuses on subjects like Physical medicine and rehabilitation, which are connected to Voxel.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease

Günther Deuschl;Carmen Schade-Brittinger;Paul Krack;Jens Volkmann.
The New England Journal of Medicine (2006)

2824 Citations

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Paul Krack;Alina Batir;Nadège Van Blercom;Stephan Chabardes.
The New England Journal of Medicine (2003)

2435 Citations

Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease

Patricia Limousin;Paul Krack;Pierre Pollak;Abdelhamid Benazzouz.
The New England Journal of Medicine (1998)

2161 Citations

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

Obeso Ja;Olanow Cw;Rodriguez-Oroz Mc.
The New England Journal of Medicine (2001)

2084 Citations

Neurostimulation for Parkinson's Disease with Early Motor Complications

W. M. M. Schuepbach;J. Rau;K. Knudsen;J. Volkmann.
The New England Journal of Medicine (2013)

1244 Citations

Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues

Jeff M. Bronstein;Michele Tagliati;Ron L. Alterman;Andres M. Lozano.
JAMA Neurology (2011)

995 Citations

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

Maria C Rodriguez-Oroz;Maria C Rodriguez-Oroz;Marjan Jahanshahi;Paul Krack;Paul Krack;Irene Litvan.
Lancet Neurology (2009)

905 Citations

Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.

Luc Mallet;Mircea Polosan;Nematollah Jaafari;Nicolas Baup.
The New England Journal of Medicine (2008)

903 Citations

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease.

Paul Krack;Pierre Pollak;P Limousin;D Hoffmann.
Brain (1998)

701 Citations

Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease

Aurelie Funkiewiez;Claire Ardouin;Elena Caputo;Paul Krack.
Journal of Neurology, Neurosurgery, and Psychiatry (2004)

695 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Paul Krack

Andres M. Lozano

Andres M. Lozano

University of Toronto

Publications: 263

Michael S. Okun

Michael S. Okun

University of Florida

Publications: 195

Marwan Hariz

Marwan Hariz

Umeå University

Publications: 182

Günther Deuschl

Günther Deuschl

Kiel University

Publications: 127

Jens Volkmann

Jens Volkmann

University of Würzburg

Publications: 116

Kelly D. Foote

Kelly D. Foote

University of Florida

Publications: 114

Peter Brown

Peter Brown

University of Oxford

Publications: 113

Ludvic Zrinzo

Ludvic Zrinzo

University College London

Publications: 111

Yasin Temel

Yasin Temel

Maastricht University

Publications: 111

Patricia Limousin

Patricia Limousin

University College London

Publications: 111

Anthony E. Lang

Anthony E. Lang

University of Toronto

Publications: 105

Alfonso Fasano

Alfonso Fasano

Krembil Research Institute

Publications: 104

Andrea A. Kühn

Andrea A. Kühn

Charité - University Medicine Berlin

Publications: 99

Thomas Foltynie

Thomas Foltynie

University College London

Publications: 95

Cameron C. McIntyre

Cameron C. McIntyre

Duke University

Publications: 93

Veerle Visser-Vandewalle

Veerle Visser-Vandewalle

University of Cologne

Publications: 89

Trending Scientists

Alberto Leon-Garcia

Alberto Leon-Garcia

University of Toronto

Vincent Tournat

Vincent Tournat

Centre national de la recherche scientifique, CNRS

Igor F. Perepichka

Igor F. Perepichka

Northwestern Polytechnical University

Shinsei Minoshima

Shinsei Minoshima

Hamamatsu University

Juha Tuomi

Juha Tuomi

University of Oulu

Samuel A. Cushman

Samuel A. Cushman

US Forest Service

Zhaozhong Feng

Zhaozhong Feng

Nanjing University of Information Science and Technology

Torleif Härd

Torleif Härd

Swedish University of Agricultural Sciences

Christopher Horst Lillig

Christopher Horst Lillig

University of Greifswald

Dmitry B. Veprintsev

Dmitry B. Veprintsev

University of Nottingham

Alan H. Sharp

Alan H. Sharp

Johns Hopkins University School of Medicine

Robert T. Abraham

Robert T. Abraham

Pfizer (United States)

Chihiro Sugimoto

Chihiro Sugimoto

Hokkaido University

Jean-Baptiste Poline

Jean-Baptiste Poline

Montreal Neurological Institute and Hospital

Charles F. Lynch

Charles F. Lynch

University of Iowa

G. Pessina

G. Pessina

University of Milano-Bicocca

Something went wrong. Please try again later.